Patent №
US 10,694,947
Granted
2020-06-30
Filed 2016
Owner
NEURAMETRIX, INC.
Lab
—
AI components
2
nlp · hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
15166064
A system and method for continuous monitoring of central nervous system diseases are provided in which typing cadence is used to measure cognitive function at a very granular level, providing hard, specific and detailed data to the neurologists about the central nervous system diseases. The system may also be used by a patient with a central nervous system disease to experiment with changes to diet, exercise and other things and test the effectiveness of those changes and patients can understand better why an unexpected improvement or worsening occurred.
AI classification
Ownership
NEURAMETRIX, INC.
assignment · 394160991
Assignors
SAMZELIUS, JAN
On an employer assignment, the assignors are typically the inventors.